 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 October 2002 | Volume 137 Issue 7 | Pages 563-570
Background: Survival is poor in patients with acute myocardial infarction (MI) who also have severe renal disease. Less is known about the outcome of acute MI in patients with mild to moderate renal insufficiency.
Objective: To compare outcomes after acute MI in patients with varying levels of renal disease and in patients without renal failure.
Design: Retrospective cohort study.
Setting: Academic medical center.
Patients: 3106 total patients admitted with acute MI and end-stage renal disease (n = 44), severe renal insufficiency (creatinine clearance < 0.59 mL/s [<35 mL/min]) (n = 391), moderate renal dysfunction (creatinine clearance
Measurements: Clinical characteristics, treatment strategies, and short- and long-term survival were compared after patients were stratified by creatinine clearance.
Results: In-hospital mortality rates were 2% in patients with normal renal function, 6% in those with mild renal failure, 14% in those with moderate renal failure, 21% in those with severe renal failure, and 30% in those with end-stage renal disease (P < 0.001). Compared with patients without renal disease, similar adjusted trends were present for postdischarge death in patients with end-stage renal disease (hazard ratio, 5.4 [95% CI, 3.0 to 9.7]; P < 0.001), severe renal insufficiency (hazard ratio, 1.9 [CI, 1.2 to 3.0]; P = 0.006), moderate renal dysfunction (hazard ratio, 2.2 [CI, 1.5 to 3.3]; P < 0.001), and mild chronic renal insufficiency (hazard ratio, 2.4 [CI, 1.7 to 3.3]; P < 0.001). Patients with renal failure received adjunctive and reperfusion therapies less frequently than those with normal renal function (P < 0.001). Postdischarge death was less likely in patients who received acute reperfusion therapy (odds ratio, 0.7 [CI, 0.6 to 0.9]), aspirin (odds ratio, 0.7 [CI, 0.5 to 0.8]), and ß-blocker therapy (odds ratio, 0.7 [CI, 0.6 to 0.9]).
Conclusion: Patients with renal failure are at increased risk for death after acute MI and receive less aggressive treatment than patients with normal renal function.
Editors' Notes
Context
Contribution
Implications
–The Editors
Author and Article Information
From Mayo Clinic, Rochester, and University of Minnesota Medical School and Hennepin County Medical Center, Minneapolis, Minnesota.
Acknowledgment: The authors thank Amy Oeltjen for excellent administrative work.
Grant Support: By the Mayo Foundation and the Mayo Alliance for Clinical Trials.
Requests for Single Reprints: R. Scott Wright, MD, Division of Cardiology, Mayo Clinic, Mayo Alliance for Clinical Trials, Stabile 5, 150 Third Street SW, Rochester, MN 55902; e-mail, wright.scott{at}mayo.edu.
Potential Financial Conflicts of Interest:Consultancies: C.A. Herzog, A.S. Jaffe; Grants received: R.S. Wright, C.A. Herzog, A.S. Jaffe; Grants pending: A.S. Jaffe.
Current Author Addresses: Drs. Wright and Kopecky and Mr. Dvorak: Division of Cardiology, Mayo Alliance for Clinical Trials, Mayo Clinic, Stabile 5, 150 Third Street SW, Rochester, MN 55902.
Drs. Reeder, Miller, Murphy, and Jaffe: Division of Cardiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Dr. Herzog: Hennepin County Medical Hospital—Cardiology, 701 Park Avenue, Mail Station 865A, Minneapolis, MN 55415.
Dr. Albright: Division of Nephrology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905.
Mr. Williams: Division of Biostatistics, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905.
Author Contributions: Conception and design: R.S. Wright, C.A. Herzog, S.L. Kopecky.
Analysis and interpretation of the data: R.S. Wright, G.S. Reeder, R.C. Albright, B.A. Williams, W.L. Miller, J.G. Murphy, S.L. Kopecky, A.S. Jaffe.
Drafting of the article: R.S. Wright, G.S. Reeder, R.C. Albright, W.L. Miller, J.G. Murphy, A.S. Jaffe.
Critical revision of the article for important intellectual content: R.S. Wright, G.S. Reeder, C.A. Herzog, R.C. Albright, W.L. Miller, J.G. Murphy, S.L. Kopecky, A.S. Jaffe.
Final approval of the article: R.S. Wright, G.S. Reeder, R.C. Albright, B.A. Williams, W.L. Miller, J.G. Murphy, S.L. Kopecky, A.S. Jaffe.
Provision of study materials or patients: D.L. Dvorak, S.L. Kopecky.
Statistical expertise: B.A. Williams, A.S. Jaffe.
Obtaining of funding: R.S. Wright, S.L. Kopecky.
Collection and assembly of data: B.A. Williams, D.L. Dvorak, A.S. Jaffe. ARTICLE
Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination
0.59 mL/s [<35 mL/min] but 
0.84 mL/s [ 50 mL/min]) (n = 491), mild chronic renal insufficiency (creatinine clearance > 0.84 mL/s [>50 mL/min] but 1.25 mL/s [ 75 mL/min]) (n = 860), or no renal disease (n = 1320).
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  T. Hasegawa, S. J. Elder, J. L. Bragg-Gresham, R. L Pisoni, S. Yamazaki, T. Akizawa, M. Jadoul, R. C. Hugh, F. K Port, and S. Fukuhara Consistent Aspirin Use Associated with Improved Arteriovenous Fistula Survival among Incident Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1373 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Winkelmayer, R. Levin, and S. Setoguchi Associations of Kidney Function with Cardiovascular Medication Use after Myocardial Infarction Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1415 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tsagalis, T. Akrivos, M. Alevizaki, E. Manios, K. Stamatellopoulos, A. Laggouranis, and K. N. Vemmos Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality Nephrol. Dial. Transplant., August 26, 2008; (2008) gfn471v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chonchol, H. Gnahn, and D. Sander Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2593 - 2598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Johnston, H. Dargie, and A. Jardine Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease Heart, August 1, 2008; 94(8): 1080 - 1088. [Full Text] [PDF]
|
|
|
|
|
|
Y. P. Liew, J. R. Bartholomew, S. Demirjian, J. Michaels, and M. J. Schreiber Jr. Combined Effect of Chronic Kidney Disease and Peripheral Arterial Disease on All-Cause Mortality in a High-Risk Population Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1084 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Parikh, S. G. Coca, Y. Wang, F. A. Masoudi, and H. M. Krumholz Long-term Prognosis of Acute Kidney Injury After Acute Myocardial Infarction Arch Intern Med, May 12, 2008; 168(9): 987 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Shirali and M. J. Bia Management of Cardiovascular Disease in Renal Transplant Recipients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 491 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pereg, A. Tirosh, T. Shochat, D. Hasdai, and for the Metabolic, Lifestyle and Nutrition Assessm Mild renal dysfunction associated with incident coronary artery disease in young males Eur. Heart J., January 2, 2008; 29(2): 198 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chonchol, M. Cigolini, and G. Targher Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction Nephrol. Dial. Transplant., January 1, 2008; 23(1): 269 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Smith, F. A. Masoudi, M. G. Shlipak, H. M. Krumholz, and C. R. Parikh Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction J. Am. Soc. Nephrol., January 1, 2008; 19(1): 141 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Banerjee, J. Z. Ma, A. J. Collins, and C. A. Herzog Long-Term Survival of Incident Hemodialysis Patients Who Are Hospitalized for Congestive Heart Failure, Pulmonary Edema, or Fluid Overload Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1186 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shepherd, J. J.P. Kastelein, V. Bittner, P. Deedwania, A. Breazna, S. Dobson, D. J. Wilson, A. Zuckerman, N. K. Wenger, and for the Treating to New Targets Investigators Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Patients with Coronary Heart Disease: The Treating to New Targets (TNT) Study Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1131 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. O. Phillips, A. Kashani, D. K. Ko, G. Francis, and H. M. Krumholz Adverse Effects of Combination Angiotensin II Receptor Blockers Plus Angiotensin-Converting Enzyme Inhibitors for Left Ventricular Dysfunction: A Quantitative Review of Data From Randomized Clinical Trials Arch Intern Med, October 8, 2007; 167(18): 1930 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Herzog, K. Littrell, C. Arko, P. D. Frederick, and M. Blaney Clinical Characteristics of Dialysis Patients With Acute Myocardial Infarction in the United States: A Collaborative Project of the United States Renal Data System and the National Registry of Myocardial Infarction Circulation, September 25, 2007; 116(13): 1465 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Glynn, D. Reddan, J. Newell, J. Hinde, B. Buckley, and A. W. Murphy Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2586 - 2594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A.A. Fox, E. M. Antman, G. Montalescot, S. Agewall, B. SomaRaju, F. W.A. Verheugt, J. Lopez-Sendon, H. Hod, S. A. Murphy, and E. Braunwald The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial J. Am. Coll. Cardiol., June 12, 2007; 49(23): 2249 - 2255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. McCullough Coronary Artery Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 611 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Redon, F. Morales-Olivas, A. Galgo, M. A. Brito, J. Mediavilla, R. Marin, P. Rodriguez, S. Tranche, J. V. Lozano, C. Filozof, et al. Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S236 - S245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend The treatment of coronary artery disease in patients with chronic kidney disease QJM, November 1, 2006; 99(11): 723 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jose, H. Skali, N. Anavekar, C. Tomson, H. M. Krumholz, J. L. Rouleau, L. Moye, M. A. Pfeffer, S. D. Solomon, and for the SAVE Investigators Increase in Creatinine and Cardiovascular Risk in Patients with Systolic Dysfunction after Myocardial Infarction J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2886 - 2891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Coca, H. M. Krumholz, A. X. Garg, and C. R. Parikh Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA, September 20, 2006; 296(11): 1377 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, L. Zuo, F. Wang, M. Wang, S. Wang, J. Lv, L. Liu, and H. Wang Cardiovascular Disease in Early Stages of Chronic Kidney Disease in a Chinese Population J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2617 - 2621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Winkelmayer, D. M. Charytan, M. A. Brookhart, R. Levin, D. H. Solomon, and J. Avorn Kidney Function and Use of Recommended Medications after Myocardial Infarction in Elderly Patients Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 796 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Abbott, R. M. Perkins, and E. M. Bohen Use of Recommended Medications after Myocardial Infarction--Is Kidney Function Really the Problem? Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 614 - 615. [Full Text] [PDF]
|
|
|
|
|
|
G. L. Smith, M. G. Shlipak, E. P. Havranek, J. M. Foody, F. A. Masoudi, S. S. Rathore, and H. M. Krumholz Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. Arch Intern Med, May 22, 2006; 166(10): 1134 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Williams Coronary Revascularization in Diabetic Chronic Kidney Disease/End-Stage Renal Disease: A Nephrologist's Perspective Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 209 - 220. [Full Text] [PDF]
|
|
|
|
|
|
R. W. Schrier Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor? J. Am. Coll. Cardiol., January 3, 2006; 47(1): 1 - 8. [Abstract] [Full Text]
|
|
|
|
|
|
H. Fujii, S. Nakamura, S. Kuroda, F. Yoshihara, H. Nakahama, T. Inenaga, H. Ueda-Ishibashi, C. Yutani, and Y. Kawano Relationship between renal artery stenosis and intrarenal damage in autopsy subjects with stroke Nephrol. Dial. Transplant., January 1, 2006; 21(1): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Khan, I. Ma, C. R. Thompson, K. Humphries, D. N. Salem, M. J. Sarnak, and A. Levin Kidney Function and Mortality among Patients with Left Ventricular Systolic Dysfunction J. Am. Soc. Nephrol., January 1, 2006; 17(1): 244 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Merx, C. Schafer, R. Westenfeld, V. Brandenburg, S. Hidajat, C. Weber, M. Ketteler, and W. Jahnen-Dechent Myocardial Stiffness, Cardiac Remodeling, and Diastolic Dysfunction in Calcification-Prone Fetuin-A-Deficient Mice J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3357 - 3364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Holzmann, S. Ahnve, N. Hammar, L. Jorgensen, K. Klerdal, K. Pehrsson, and T. Ivert Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 746 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sarnak, R. Katz, C. O. Stehman-Breen, L. F. Fried, N. S. Jenny, B. M. Psaty, A. B. Newman, D. Siscovick, M. G. Shlipak, and and the Cardiovascular Health Study* Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults Ann Intern Med, April 5, 2005; 142(7): 497 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Foley, A. M. Murray, S. Li, C. A. Herzog, A. M. McBean, P. W. Eggers, and A. J. Collins Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999 J. Am. Soc. Nephrol., February 1, 2005; 16(2): 489 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Lentine, D. C. Brennan, and M. A. Schnitzler Incidence and Predictors of Myocardial Infarction after Kidney Transplantation J. Am. Soc. Nephrol., February 1, 2005; 16(2): 496 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. O'Hare, D. Bertenthal, M. G. Shlipak, S. Sen, and M.-M. Chren Impact of Renal Insufficiency on Mortality in Advanced Lower Extremity Peripheral Arterial Disease J. Am. Soc. Nephrol., February 1, 2005; 16(2): 514 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam The severe cardiorenal syndrome: 'Guyton revisited' Eur. Heart J., January 1, 2005; 26(1): 11 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Tokmakova, H. Skali, S. Kenchaiah, E. Braunwald, J. L. Rouleau, M. Packer, G. M. Chertow, L. A. Moye, M. A. Pfeffer, and S. D. Solomon Chronic Kidney Disease, Cardiovascular Risk, and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction: The Survival And Ventricular Enlargement (SAVE) Study Circulation, December 14, 2004; 110(24): 3667 - 3673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Yan, R. T. Yan, M. Tan, C.-M. Chow, D. Fitchett, E. Stanton, A. Langer, S. G. Goodman, and for the Canadian Acute Coronary Syndromes Registr Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients Eur. Heart J., November 2, 2004; 25(22): 2006 - 2012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J.M. Best, P. B. Berger, B. R. Davis, C. L. Grines, H. M. Sadeghi, B. A. Williams, J. T. Willerson, J. R. Granett, D. R. Holmes Jr, and PRESTO Investigators Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO trial J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1786 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ezekowitz, F. A. McAlister, K. H. Humphries, C. M. Norris, M. Tonelli, W. A. Ghali, M. L. Knudtson, and APPROACH Investigators The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1587 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jernberg, B. Lindahl, S. James, A. Larsson, L.-O. Hansson, and L. Wallentin Cystatin C: A Novel Predictor of Outcome in Suspected or Confirmed Non-ST-Elevation Acute Coronary Syndrome Circulation, October 19, 2004; 110(16): 2342 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gupta, Y. Birnbaum, and B. F. Uretsky The renal patient with coronary artery disease: Current concepts and dilemmas J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1343 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Anavekar, J. J.V. McMurray, E. J. Velazquez, S. D. Solomon, L. Kober, J.-L. Rouleau, H. D. White, R. Nordlander, A. Maggioni, K. Dickstein, et al. Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction N. Engl. J. Med., September 23, 2004; 351(13): 1285 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tonelli, C. Isles, G. C. Curhan, A. Tonkin, M. A. Pfeffer, J. Shepherd, F. M. Sacks, C. Furberg, S. M. Cobbe, J. Simes, et al. Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease Circulation, September 21, 2004; 110(12): 1557 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Keeley and C. L. Grines Primary Percutaneous Coronary Intervention for Every Patient with ST-Segment Elevation Myocardial Infarction: What Stands in the Way? Ann Intern Med, August 17, 2004; 141(4): 298 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M W Yerkey, S J Kernis, B A Franklin, K R Sandberg, and P A McCullough Renal dysfunction and acceleration of coronary disease Heart, August 1, 2004; 90(8): 961 - 966. [Full Text] [PDF]
|
|
|
|
|
|
W. M. McClellan, R. D. Langston, and R. Presley Medicare Patients with Cardiovascular Disease Have a High Prevalence of Chronic Kidney Disease and a High Rate of Progression to End-Stage Renal Disease J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1912 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Blankestijn Sympathetic hyperactivity in chronic kidney disease Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1354 - 1357. [Full Text] [PDF]
|
|
|
|
|
|
R. Dikow, L. P. Kihm, M. Zeier, J. Kapitza, J. Tornig, K. Amann, C. Tiefenbacher, and E. Ritz Increased Infarct Size in Uremic Rats: Reduced Ischemia Tolerance? J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1530 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Amann, M.-L. Gross, and E. Ritz Pathophysiology Underlying Accelerated Atherogenesis in Renal Disease: Closing in on the Target J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1664 - 1666. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Weiner, H. Tighiouart, M. G. Amin, P. C. Stark, B. MacLeod, J. L. Griffith, D. N. Salem, A. S. Levey, and M. J. Sarnak Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality: A Pooled Analysis of Community-Based Studies J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1307 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
Article
